On the other hand, SA-modified liposomal formulation, based on the high expression of L-selectin in peripheral blood neutrophils and SA as its targeting ligand have been proved to be an effective neutrophil-mediated drug delivery system targeting RA (54). Here, SELL is linked to rheumatoid arthritis.